Mequitamium iodide

Drug Profile

Mequitamium iodide

Alternative Names: LG 30435; Mequitazium iodide

Latest Information Update: 12 Apr 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Guidotti
  • Developer Guidotti; SOGERAS
  • Class Antiallergics; Antiasthmatics; Bronchodilators; Small molecules
  • Mechanism of Action Histamine H1 receptor antagonists; Mast cell stabilisers; Muscarinic receptor antagonists; Platelet activating factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Rhinitis

Most Recent Events

  • 12 Apr 2000 Discontinued-II for Asthma in Europe (Inhalation)
  • 12 Apr 2000 Discontinued-II for Asthma in France (Inhalation)
  • 12 Apr 2000 Discontinued-II for Asthma in Italy (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top